{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:26:58Z","timestamp":1792610818794,"version":"4.5.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Cutibacterium acnes<\/jats:italic> (<jats:italic>C. acnes<\/jats:italic>) is closely related to the pathogenesis of acne, and studies related to the antibiotic resistance rates of <jats:italic>C. acnes<\/jats:italic> have been reported worldwide; however, relevant systematic reviews and meta-analyses are still lacking. The aim of this study was to systematically evaluate the resistance in <jats:italic>C. acnes<\/jats:italic> to relevant antibiotics, that this information may be used to provide a rational basis for the antibiotic treatment of acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Relevant studies in PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI) and Wanfang Data were systematically searched from January 1, 2005, to April 1, 2025, and the resistance rates of <jats:italic>C. acnes<\/jats:italic> isolates to quinolones, macrolides, tetracyclines, and other relevant antibiotics were collected. The combined resistance rate was calculated via the <jats:italic>R<\/jats:italic> language program package 4.3.2, with subgroup analyses based on different years, continents, countries, provinces in China and different drug susceptibility testing methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 8,846 studies were systematically retrieved and 23 studies were included, corresponding to 2,046 isolates of <jats:italic>C. acnes<\/jats:italic>, which have shown antibiotic resistance rates ranging from high to low: 48.17% (95% CI: 41.16\u201355.24%) for roxithromycin, 45.64% (95% CI: 20.49\u201373.22%) for clarithromycin, 43.33% (95% CI: 27.81\u201360.29%) for azithromycin, 29.20% (95% CI: 22.14\u201337.43%) for erythromycin, 22.38% (95% CI: 14.69\u201332.56%) for clindamycin, 5.93% (95% CI: 2.91\u201311.69%) for levofloxacin, 2.44% (95% CI: 0.99\u20135.89%) for doxycycline, 1.47% (95% CI: 0.00\u201385.72%) for trimethoprim-sulfamethoxazole (TMP\u2013SMX), 1.31% (95% CI: 0.45\u20133.70%) for tetracycline, 0.28% (95% CI: 0.04\u20131.94%) for chloramphenicol, 0.22% (95% CI: 0.03\u20131.89%) for minocycline. Subgroup analysis revealed that, compared with those in other regions, the resistance rates to macrolides and clindamycin were higher in China. In addition, the levofloxacin, erythromycin, and clindamycin resistance rates were progressively increasing over time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In certain regions, the relatively high antibiotic resistance rates (e.g., 77% (95% CI: 62\u201387%) for clarithromycin in China) in <jats:italic>C. acnes<\/jats:italic> isolates may be attributed to the overuse of antibiotics in acne treatment. The resistance rates in <jats:italic>C. acnes<\/jats:italic> to tetracyclines, such as 2.44% (95% CI: 0.99\u20135.89%) for doxycycline, remain relatively low, which allows tetracyclines to continue serving as first-line antibiotics for acne treatment. In addition, the resistance rates to levofloxacin, erythromycin, and clindamycin markedly increased over time (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). This emphasizes the significance of rational use of the antibiotics in acne treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2025.1565111","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:38:02Z","timestamp":1749015482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Antibiotic resistance rates in Cutibacterium acnes isolated from patients with acne vulgaris: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunxiao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/jdv.12057","article-title":"In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study","volume":"27","author":"Abdel Fattah","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1128\/CMR.00092-13","article-title":"Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen","volume":"27","author":"Achermann","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jamadermatol.2017.1297","article-title":"Antibiotic resistance in acne treatment","volume":"153","author":"Adler","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/jid.2013.334","article-title":"Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin a and vitamin D","volume":"134","author":"Agak","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12895-020-00108-9","article-title":"Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study","volume":"20","author":"Alkhawaja","year":"2020","journal-title":"BMC Dermatol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"106207","DOI":"10.1016\/j.archoralbio.2025.106207","article-title":"Whole-genome sequencing analysis of Cutibacterium spp. recovered from health care-associated endodontic infections","volume":"173","author":"Alvarez-Munoz","year":"2025","journal-title":"Arch. Oral Biol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.circir.2015.08.005","article-title":"Bacterial resistance in acne? A meta-analysis of the controversy","volume":"84","author":"Alvarez-Sanchez","year":"2016","journal-title":"Cir. Cir."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/1346-8138.15940","article-title":"Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors","volume":"48","author":"Aoki","year":"2021","journal-title":"J. Dermatol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1099\/jmm.0.000875","article-title":"Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes","volume":"68","author":"Aoki","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e01810-19","DOI":"10.1128\/AAC.01810-19","article-title":"Transferable multidrug-resistance plasmid carrying a novel macrolide-clindamycin resistance gene, erm(50), in Cutibacterium acnes","volume":"64","author":"Aoki","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"682682","DOI":"10.3389\/fmicb.2021.682682","article-title":"A complementary mechanism of bacterial mRNA translation inhibition by tetracyclines","volume":"12","author":"Barrenechea","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jgar.2024.07.005","article-title":"Prevalence of antibiotic-resistant Cutibacterium acnes (formerly Propionibacterium acnes) isolates, a systematic review and meta-analysis","volume":"39","author":"Beig","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/cid\/ciy379","article-title":"Association of Cutibacterium avidum colonization in the groin with obesity: a potential risk factor for hip periprosthetic joint infection","volume":"67","author":"Boni","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s10096-020-03852-5","article-title":"Propionibacterium\/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital","volume":"39","author":"Broly","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ad.2021.05.004","article-title":"Cutibacterium acnes tetracycline resistance profile in patients with acne vulgaris, in a Colombian dermatologic center","volume":"112","author":"Castellanos Lorduy","year":"2021","journal-title":"Actas Dermosifiliogr. (Engl. Ed.)"},{"key":"ref17","volume-title":"28th informational supplement. CLSI M100-S28","year":"2018"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00403-019-01908-x","article-title":"From pathogenesis of acne vulgaris to anti-acne agents","volume":"311","author":"Cong","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/AAC.47.12.3675-3681.2003","article-title":"Ribosomal protection proteins and their mechanism of tetracycline resistance","volume":"47","author":"Connell","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1784","DOI":"10.1016\/j.idcr.2023.e01784","article-title":"Clinical spectrum of Cutibacterium acnes infections: the SAPHO syndrome","volume":"32","author":"Corbisiero","year":"2023","journal-title":"Idcases"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.23736\/S0392-0488.20.06711-5","article-title":"Acne fulminans","volume":"155","author":"Dall'Oglio","year":"2020","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.anaerobe.2021.102411","article-title":"Unravelling the eco-specificity and pathophysiological properties of Cutibacterium species in the light of recent taxonomic changes","volume":"71","author":"Dekio","year":"2021","journal-title":"Anaerobe"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/antibiotics11070832","article-title":"Spread of multidrug-resistant microorganisms","volume":"11","author":"Di Lodovico","year":"2022","journal-title":"Antibiotics-Basel"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40257-020-00531-1","article-title":"The skin microbiome: a new actor in inflammatory acne","volume":"21","author":"Dreno","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15043","article-title":"Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates","volume":"32","author":"Dreno","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-4632.2009.04270.x","article-title":"Bacterial resistance in French acne patients","volume":"49","author":"Dumont-Wallon","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref29","article-title":"European committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters","year":"2019"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/1346-8138.13149","article-title":"Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris","volume":"43","author":"Fan","year":"2016","journal-title":"J. Dermatol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antibiotics6040025","article-title":"Identification and antimicrobial susceptibility testing of anaerobic bacteria: Rubik's cube of clinical microbiology?","volume":"6","author":"Gajdacs","year":"2017","journal-title":"Antibiotics-Basel"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1542\/peds.2019-2056L","article-title":"Current issues in the treatment of acne vulgaris","volume":"145","author":"Habeshian","year":"2020","journal-title":"Pediatrics"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/1346-8138.14355","article-title":"Japanese dermatological association guidelines: guidelines for the treatment of acne vulgaris 2017","volume":"45","author":"Hayashi","year":"2018","journal-title":"J. Dermatol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"102944","DOI":"10.1016\/j.anaerobe.2025.102944","article-title":"Cutibacterium avidum: a virulent pathogen in esthetic surgery infection, a case series","volume":"92","author":"Isabel Cristina","year":"2025","journal-title":"Anaerobe"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1348-0421.2008.00081.x","article-title":"Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris","volume":"52","author":"Ishida","year":"2008","journal-title":"Microbiol. Immunol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.anaerobe.2016.10.001","article-title":"Transcriptomic analysis of Propionibacterium acnes biofilms in vitro","volume":"42","author":"Jahns","year":"2016","journal-title":"Anaerobe"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jdv.16686","article-title":"Antibiotic resistance in acne: changes, consequences and concerns","volume":"35","author":"Karadag","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e9422","DOI":"10.1128\/mra.00094-22","article-title":"Identification of a transferable linear plasmid carrying the macrolide-clindamycin resistance gene erm(X) in a Cutibacterium acnes isolate from a patient with acne vulgaris in Japan","volume":"11","author":"Koizumi","year":"2022","journal-title":"Microbiol. Resour. Announc."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12879-022-07341-2","article-title":"A case report of native vertebral osteomyelitis caused by Cutibacterium modestum","volume":"22","author":"Koyama","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/1346-8138.16757","article-title":"Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes","volume":"50","author":"Koyanagi","year":"2023","journal-title":"J. Dermatol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00894-018-3689-5","article-title":"Molecular dynamics simulations suggest why the A2058G mutation in 23S RNA results in bacterial resistance against clindamycin","volume":"24","author":"Kulczycka-Mierzejewska","year":"2018","journal-title":"J. Mol. Model."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","article-title":"A general overview of mantel-Haenszel methods: applications and recent developments","volume":"9","author":"Kuritz","year":"1988","journal-title":"Annu. Rev. Public Health"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e1064","DOI":"10.1093\/cid\/ciaa1839","article-title":"The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections","volume":"72","author":"Kusejko","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref9002","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/jcm8070987","article-title":"Potential role of the microbiome in acne: a comprehensive review","volume":"8","author":"Lee","year":"2019","journal-title":"J. Clin. Med."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1468-3083.2011.04351.x","article-title":"Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin Centre in Hong Kong","volume":"27","author":"Luk","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11684-016-0480-9","article-title":"Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China","volume":"10","author":"Ma","year":"2016","journal-title":"Front. Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jocd.2012.03.005","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"J. Clin. Densitom."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1365-4632.2011.05403.x","article-title":"Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia","volume":"52","author":"Mendoza","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.18793","article-title":"Myrtus communis and Celastrol enriched plant cell culture extracts control together the pivotal role of Cutibacterium acnes and inflammatory pathways in acne","volume":"37","author":"Mias","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.cmi.2018.02.008","article-title":"How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories","volume":"24","author":"Nagy","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.0022-202X.2005.23705.x","article-title":"Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors","volume":"124","author":"Nagy","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/1346-8138.15397","article-title":"Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: a Japanese multicenter study","volume":"47","author":"Nakase","year":"2020","journal-title":"J. Dermatol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/1346-8138.13913","article-title":"Antimicrobial susceptibility and phylogenetic analysis of Propionibacterium acnes isolated from acne patients in Japan between 2013 and 2015","volume":"44","author":"Nakase","year":"","journal-title":"J. Dermatol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1099\/jmm.0.000392","article-title":"Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines","volume":"66","author":"Nakase","year":"","journal-title":"J. Med. Microbiol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/1346-8138.14178","article-title":"Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes","volume":"45","author":"Nakase","year":"2018","journal-title":"J. Dermatol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.anaerobe.2016.10.012","article-title":"Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV","volume":"42","author":"Nakase","year":"2016","journal-title":"Anaerobe"},{"key":"ref58","volume-title":"Approved standards","year":"2004"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000081032","article-title":"Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic gram-positive bacteria isolated from bacterial skin infections","volume":"50","author":"Nenoff","year":"2004","journal-title":"Chemotherapy"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.3390\/molecules24193430","article-title":"Comparison of antibiotic resistance mechanisms in antibiotic-producing and pathogenic bacteria","volume":"24","author":"Ogawara","year":"2019","journal-title":"Molecules"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1469-0691.2004.01055.x","article-title":"European surveillance study on the antibiotic susceptibility of Propionibacterium acnes","volume":"11","author":"Oprica","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/ajd.12075","article-title":"Non-antibiotic properties of tetracyclines and their clinical application in dermatology","volume":"55","author":"Perret","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.12688\/f1000research.15659.1","article-title":"Recent advances in understanding Propionibacterium acnes (Cutibacterium acnes) in acne","volume":"7","author":"Platsidaki","year":"2018","journal-title":"F1000Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"107797","DOI":"10.1016\/j.bioelechem.2021.107797","article-title":"Growth in a biofilm sensitizes Cutibacterium acnes to nanosecond pulsed electric fields","volume":"140","author":"Poudel","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jac\/49.1.165","article-title":"Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities","volume":"49","author":"Ross","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/ijd.17194","article-title":"Biofilm of Cutibacterium acnes: a target of different active substances","volume":"63","author":"Ruffier D'Epenoux","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jaad.2020.02.040","article-title":"Acne vulgaris and risk of depression and anxiety: a meta-analytic review","volume":"83","author":"Samuels","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-4632.2011.05371.x","article-title":"Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne","volume":"52","author":"Schafer","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"adv00295","DOI":"10.2340\/00015555-3654","article-title":"Antibiotic susceptibility of Cutibacterium acnes strains isolated from Israeli acne patients","volume":"100","author":"Sheffer-Levi","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1346-8138.2010.01109.x","article-title":"Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea","volume":"38","author":"Song","year":"2011","journal-title":"J. Dermatol."},{"key":"ref75","first-page":"470","article-title":"Bias in meta-analysis detected by a simple, graphical test. asymmetry detected in funnel plot was probably due to true heterogeneity","author":"Stuck","year":"1998","journal-title":"BMJ"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"102169","DOI":"10.1016\/j.anaerobe.2020.102169","article-title":"Susceptibility of Cutibacterium acnes to topical minocycline foam","volume":"62","author":"Sutcliffe","year":"2020","journal-title":"Anaerobe"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21307\/pjm-2018-028","article-title":"New gene responsible for resistance of clinical Corynebacteria to macrolide, lincosamide and streptogramin B","volume":"67","author":"Szemraj","year":"2018","journal-title":"Pol. J. Microbiol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jaad.2019.04.012","article-title":"Changes in the management of acne: 2009-2019","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1440-0960.2011.00867.x","article-title":"Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice","volume":"53","author":"Toyne","year":"2012","journal-title":"Australas. J. Dermatol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I2 can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40257-018-00417-3","article-title":"Acne, the skin microbiome, and antibiotic treatment","volume":"20","author":"Xu","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bjd.16380","article-title":"A profile of Propionibacterium acnes resistance and sensitivity at a tertiary dermatological Centre in Singapore","volume":"179","author":"Yang","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12328-020-01283-5","article-title":"Liver abscess caused by Cutibacterium namnetense after transarterial chemoembolization for hepatocellular carcinoma","volume":"14","author":"Yasutomi","year":"2021","journal-title":"Clin. J. Gastroenterol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jgar.2017.10.008","article-title":"Draft genome sequences of three multidrug-resistant Cutibacterium (formerly Propionibacterium) acnes strains isolated from acne patients, China","volume":"11","author":"Zhang","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"e22938","DOI":"10.1136\/bmjopen-2018-022938","article-title":"Antibiotic susceptibility of Propionibacterium acnes isolated from patients with acne in a public hospital in Southwest China: prospective cross-sectional study","volume":"9","author":"Zhu","year":"2019","journal-title":"BMJ Open"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1565111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:38:03Z","timestamp":1749015483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1565111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":86,"alternative-id":["10.3389\/fmicb.2025.1565111"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1565111","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1565111"}}